LFMD Q2 2022 Earnings — LifeMD, Inc. Revenue & Financial Results | Market Cap Arena

LFMDLifeMD, Inc.

$182M

Q2 2022 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$30M+36.5% YoY

Gross Profit

$26M84.8% margin

Operating Income

-$13M-42.4% margin

Net Income

-$13M-42.7% margin

EPS (Diluted)

$-0.42

QoQ Revenue Growth

+4.9%

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$10M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$38M

Total Liabilities

$31M

Stockholders' Equity

$8M

Cash & Equivalents

$12M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$30M	$22M	+36.5%
Gross Profit	$26M	$18M	+41.9%
Operating Income	-$13M	-$16M	+20.0%
Net Income	-$13M	-$17M	+22.6%